Clinical Trials Browser

Phase 1/2 × Neuroendocrine Tumors × 177Lu-DOTA-JR11 × Clear all

NCT02592707 2023-07-19

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Phase 1/2 Terminated

40 enrolled 37 charts

Neuroendocrine Tumors